AWS Public Sector Blog

Category: Life Sciences

AWS branded background design with text overlay that says "34 new or updated datasets available on the Registry of Open Data on AWS"

34 new or updated datasets available on the Registry of Open Data on AWS

The Amazon Web Services (AWS) Open Data Sponsorship Program makes high-value, cloud-optimized datasets publicly available on AWS. Through this program, customers are making more than 100 petabytes (PB) of high-value, cloud-optimized data available for public use. Read this blog post to learn about the 34 new or updated datasets that were released in the first quarter.

AWS branded background graphic with text overlay that says "New AWS survey reinforces need to accelerate AI fluency in healthcare"

New AWS survey reinforces need to accelerate AI fluency in healthcare

Access Partnership recently conducted a study commissioned by Amazon Web Services (AWS) on artificial intelligence (AI) skills across various industries globally. The results underscored the need to address low rates of AI fluency among healthcare leaders and employees, and this blog post provides a summary and analysis of the study’s key findings.

AWS branded background with text overlay that says "Announcing the 2023-2024 AWS IMAGINE Grant winners"

Announcing the 2023-2024 AWS IMAGINE Grant winners

Each year, Amazon Web Services (AWS) awards IMAGINE Grants to nonprofit organizations using cloud technology to drive mission-critical impact for their beneficiaries. Learn more about the IMAGINE Grant program and this year’s winners, who were announced today at our re:Invent 2023 conference.

AWS branded background with text overlay that says "34 new or updated datasets available on the Registry of Open Data on AWS"

34 new or updated datasets available on the Registry of Open Data on AWS

This quarter, AWS released 34 new or updated datasets on the Register of Open Data. What will you build with these datasets? Read through this blog post for inspiration.

AMILI helps advance precision medicine by building microbiome library on AWS

AMILI is a healthcare technology (HealthTech) company based in Singapore that seeks to advance precision medicine and personalized health and nutrition by harnessing the potential of the microbiome. AMILI uses artificial intelligence (AI) and machine learning (ML) on AWS to comprehensively quantify and characterize gut microbiomes. AMILI aims to build and curate the world’s largest multi-ethnic Asia microbiome database.

How Digithurst and Telepaxx built a secure and scalable radiology solution chain using AWS

Medical software development companies Digithurst and Telepaxx worked together to create an end-to-end cloud solution chain handling administration of patient data and their radiological scans; viewing and editing of scans; as well as long-term archiving. To develop a scalable, secure, and cost effective solution chain supporting further innovations, the companies turned to the AWS Cloud.

Scientist looks at an image of a brain scan on a computer.

34 new or updated datasets on the Registry of Open Data: New data for land use, Alzheimer’s Disease, and more

The AWS Open Data Sponsorship Program makes high-value, cloud-optimized datasets publicly available on AWS. This quarter, AWS released 34 new or updated datasets from Impact Observatory, The Allen Institute for Brain Science, Common Screens, and others, which are available now on the Registry of Open Data in the following categories.

Japan’s High Energy Accelerator Research Organization, KEK, accelerates search for new vaccines with AWS

Japan’s High Energy Accelerator Research Organization (KEK), is a Nobel Award-winning Inter-University Research Institute, and one of the world’s leading accelerator research institutes. To further help researchers understand human biology, AWS and KEK recently announced a collaboration to develop GoToCloud, a KEK-led cloud platform that makes protein analysis faster and more cost-effective, boosting KEK’s research efforts and improving our understanding of disease. This initiative has also accelerated the digital transformation of Japan’s scientific research infrastructure, helping scientists discover new medicines and produce world-class research results using cloud technology.

Driving innovation in single-cell analysis on AWS

Computational biology is undergoing a revolution. However, the analysis of single cells is a hard problem to solve. Standard statistical techniques used in genomic analysis fail to capture the complexity present in single-cell datasets. Open Problems in Single-Cell Analysis is a community-driven effort using AWS to drive the development of novel methods that leverage the power of single-cell data.